Repligen Corporation
RGEN
$157.39
-$4.27-2.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.91% | 14.81% | 10.44% | 0.56% | 9.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.91% | 14.81% | 10.44% | 0.56% | 9.69% |
| Cost of Revenue | 16.33% | 16.37% | 2.60% | 8.42% | -7.35% |
| Gross Profit | 27.28% | 13.35% | 18.13% | -6.79% | 33.24% |
| SG&A Expenses | -0.38% | 6.28% | 14.24% | -33.70% | 36.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.39% | 13.35% | 7.91% | -7.46% | 8.70% |
| Operating Income | 370.88% | 49.34% | 82.70% | 63.74% | 16.26% |
| Income Before Tax | 1,589.30% | 101.78% | 114.97% | -2,170.13% | -110.10% |
| Income Tax Expenses | 544.65% | 1.06% | 429.57% | -125.87% | 91.07% |
| Earnings from Continuing Operations | 2,379.97% | 160.21% | 76.88% | -105.89% | -103.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,379.97% | 160.21% | 76.88% | -105.89% | -103.86% |
| EBIT | 370.88% | 49.34% | 82.70% | 63.74% | 16.26% |
| EBITDA | 156.90% | 26.73% | 27.61% | 36.26% | 22.14% |
| EPS Basic | 2,364.96% | 158.71% | 75.80% | -105.02% | -103.86% |
| Normalized Basic EPS | 630.96% | 38.55% | 110.12% | 21.58% | 60.16% |
| EPS Diluted | 2,322.22% | 160.00% | 69.20% | -106.89% | -103.90% |
| Normalized Diluted EPS | 627.41% | 39.30% | 111.13% | 21.58% | 62.81% |
| Average Basic Shares Outstanding | 0.45% | 0.63% | 0.60% | 0.43% | 0.44% |
| Average Diluted Shares Outstanding | 0.93% | 0.13% | 0.05% | 0.43% | -1.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |